These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens. Hoque KE; West AR Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069 [TBL] [Abstract][Full Text] [Related]
4. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex. Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291 [TBL] [Abstract][Full Text] [Related]
5. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
6. Long-lasting behavioral effects of quinpirole exposure on zebrafish. Nabinger DD; Altenhofen S; Peixoto JV; da Silva JMK; Bonan CD Neurotoxicol Teratol; 2021; 88():107034. PubMed ID: 34600099 [TBL] [Abstract][Full Text] [Related]
7. Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats. Guo M; Xiang T; Li M; Sun Y; Sun S; Chen D; Jia Q; Li Y; Yao X; Wang X; Zhang X; He F; Wang M Behav Brain Res; 2021 Aug; 411():113339. PubMed ID: 33945831 [TBL] [Abstract][Full Text] [Related]
8. Activation of dopamine D Liu XY; Zheng LF; Fan YY; Shen QY; Qi Y; Li GW; Sun Q; Zhang Y; Feng XY; Zhu JX Am J Physiol Cell Physiol; 2022 Mar; 322(3):C327-C337. PubMed ID: 34986020 [TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity. Sammut S; Bray KE; West AR Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493 [TBL] [Abstract][Full Text] [Related]
10. Acute administration of a dopamine D2/D3 receptor agonist alters behavioral and neural parameters in adult zebrafish. Nabinger DD; Altenhofen S; Buatois A; Facciol A; Peixoto JV; da Silva JMK; Chatterjee D; Rübensam G; Gerlai R; Bonan CD Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jul; 125():110753. PubMed ID: 36934998 [TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release. Nimitvilai S; Herman M; You C; Arora DS; McElvain MA; Roberto M; Brodie MS Neuropharmacology; 2014 Jul; 82():28-40. PubMed ID: 24657149 [TBL] [Abstract][Full Text] [Related]
12. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Perreault ML; Graham D; Scattolon S; Wang Y; Szechtman H; Foster JA Psychopharmacology (Berl); 2007 Nov; 194(4):485-96. PubMed ID: 17619861 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice. Cook CD; Newman JL; Winfree JC; Beardsley PM Pharmacol Biochem Behav; 2004 Feb; 77(2):309-18. PubMed ID: 14751459 [TBL] [Abstract][Full Text] [Related]
14. Influence of 3-nitropropionic acid on physiological and behavioral responses in zebrafish larvae and adults. Wiprich MT; Zanandrea R; Altenhofen S; Bonan CD Comp Biochem Physiol C Toxicol Pharmacol; 2020 Aug; 234():108772. PubMed ID: 32353558 [TBL] [Abstract][Full Text] [Related]
15. Cesarean plus anoxia at birth induces hyperresponsiveness to locomotor activity by dopamine D2 agonist. Juárez I; De La Cruz F; Zamudio S; Flores G Synapse; 2005 Dec; 58(4):236-42. PubMed ID: 16206184 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats. Escobar AP; González MP; Meza RC; Noches V; Henny P; Gysling K; España RA; Fuentealba JA; Andrés ME Int J Neuropsychopharmacol; 2017 Aug; 20(8):660-669. PubMed ID: 28531297 [TBL] [Abstract][Full Text] [Related]
18. Low-level lead exposure modulates effects of quinpirole and eticlopride on response rates in a fixed-interval schedule. Areola OO; Jadhav AL Pharmacol Biochem Behav; 2001; 69(1-2):151-6. PubMed ID: 11420080 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease. Gupta S; Sharma B Brain Res Bull; 2014 Mar; 102():57-68. PubMed ID: 24582883 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of dopamine receptor agonists ropinirole and quinpirole on locomotor and anxiolytic behaviors in larval zebrafish (Danio rerio): A role for the GABAergic and glutamate system? Wengrovitz A; Ivantsova E; Crespo N; Patel M; Souders CL; Martyniuk CJ Neurotoxicol Teratol; 2023; 98():107183. PubMed ID: 37211288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]